Status:
COMPLETED
Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding
Lead Sponsor:
Lindenwood University
Conditions:
Amino Acid Absorption
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the pharmacokinetic pattern of amino acid absorption after a two-week pattern of milk protein supplementation with and without the addition of Bacillus coagulan...
Detailed Description
The study will be conducted using a randomized, double-blind, crossover study design. 30 healthy men and women between the ages of 18 - 55 years of age will be recruited to participate in this study. ...
Eligibility Criteria
Inclusion
- All participants will be between the ages of 18-55 years.
- Participants will be healthy and free of disease as determined by evaluation of a medical history.
- Completing at least 30 minutes of moderate exercise three days per week
Exclusion
- Those individuals less than 18 and greater than 55 years of age will be excluded.
- Any individual who is currently being treated for or diagnosed with a cardiac disorder or disease
- Any individual who is currently being treated for or diagnosed with a respiratory disorder or disease
- Any individual who is currently being treated for or diagnosed with a circulatory disorder or disease
- Any individual who is currently being treated for or diagnosed with a musculoskeletal disorder or disease
- Any individual who is currently being treated for or diagnosed with a metabolic disorder or disease
- Any individual who is currently being treated for or diagnosed with obesity (defined as body mass index \> 30 kg/m and body fat greater than 30%)
- Any individual who is currently being treated for or diagnosed with an immune or autoimmune disorder or disease
- Any individual who is currently being treated for or diagnosed with a psychiatric disorder or disease
- Any individual who is currently being treated for or diagnosed with a hematological disorder or disease
- Any individual who is currently being treated for or diagnosed with a neurological disorder or disease
- Any individual who is currently being treated for or diagnosed with an endocrinological disorder or disease
- Participants who are determined to not be weight stable defined as measured body mass deviating by 2% or more.
- Participants who do not or are not willing to abstain from alcohol, nicotine, and caffeine for 12 hours prior to each visit will be excluded
- Participants who do not or are not willing to abstain from exercise for 12 hours prior to each visit will be excluded.
Key Trial Info
Start Date :
August 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04427020
Start Date
August 8 2019
End Date
December 3 2019
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lindenwood University
Saint Charles, Missouri, United States, 63301